Wolverine Trading
AGIO icon

Wolverine Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Wolverine Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$448K Buy
11,400
+3,200
+39% +$120K ﹤0.01% 3839
2025
Q2 		$274K Buy
+8,200
New +$249K ﹤0.01% 3577
2025
Q1 		– Sell
-7,600
Closed -$251K – 4661
2024
Q4 		$251K Sell
7,600
-3,800
-33% -$179K ﹤0.01% 4239
2024
Q3 		$520K Buy
+11,400
New +$518K ﹤0.01% 3021
2023
Q2 		– Sell
-12,000
Closed -$271K – 4182
2023
Q1 		$271K Sell
12,000
-1,000
-8% -$26.6K ﹤0.01% 3114
2022
Q4 		$365K Buy
13,000
+200
+2% +$5.64K ﹤0.01% 2603
2022
Q3 		$366K Buy
+12,800
New +$343K ﹤0.01% 2942
2021
Q2 		– Sell
-7,500
Closed -$369K – 5785
2021
Q1 		$369K Sell
7,500
-4,800
-39% -$238K ﹤0.01% 4166
2020
Q4 		$548K Buy
+12,300
New +$486K ﹤0.01% 3070
2020
Q3 		– Sell
-8,400
Closed -$445K – 4436
2020
Q2 		$445K Sell
8,400
-3,600
-30% -$167K ﹤0.01% 2867
2020
Q1 		$425K Buy
+12,000
New +$555K ﹤0.01% 2845
2019
Q4 		– Sell
-18,800
Closed -$648K – 4588
2019
Q3 		$648K Buy
18,800
+9,800
+109% +$406K ﹤0.01% 2363
2019
Q2 		$449K Sell
9,000
-15,200
-63% -$812K ﹤0.01% 2824
2019
Q1 		$1.63M Buy
24,200
+13,700
+130% +$798K ﹤0.01% 1700
2018
Q4 		$476K Buy
+10,500
New +$648K ﹤0.01% 2679
2017
Q3 		– Sell
-9,100
Closed -$477K – 4347
2017
Q2 		$477K Sell
9,100
-3,500
-28% -$179K ﹤0.01% 2481
2017
Q1 		$722K Buy
12,600
+2,600
+26% +$125K ﹤0.01% 1995
2016
Q4 		$417K Buy
+10,000
New +$525K ﹤0.01% 2842

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wolverine Trading's AGIO Position: Q1 2021 in Review

Wolverine Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 4,945 shares — an estimated $245K sold.

Wolverine Trading first reported a position in AGIO in Q2 2017 and held it in 4 quarters. The position peaked at $341K in Q2 2019. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Wolverine Trading reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 4,945 Agios Pharmaceuticals shares in Q1 2021, an estimated $245K.
  • Wolverine Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Agios Pharmaceuticals position peaked at $341K in Q2 2019.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.